2015 Q2 Form 10-Q Financial Statement

#000114420415031550 Filed on May 15, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $1.341M $1.158M $1.134M
YoY Change 41.2% 2.1% -9.36%
Cost Of Revenue $1.140M $1.103M $1.083M
YoY Change 4.59% 1.8% 1.67%
Gross Profit $205.0K $55.20K $50.91K
YoY Change -250.53% 8.43% -72.62%
Gross Profit Margin 15.29% 4.77% 4.49%
Selling, General & Admin $1.150M $964.8K $886.3K
YoY Change 16.16% 8.86% 3.67%
% of Gross Profit 561.08% 1747.94% 1741.03%
Research & Development $160.0K $141.4K $153.6K
YoY Change -20.0% -7.95% -0.98%
% of Gross Profit 78.06% 256.17% 301.75%
Depreciation & Amortization $150.0K $140.0K $170.0K
YoY Change -16.67% -17.65% -5.56%
% of Gross Profit 73.18% 253.64% 333.95%
Operating Expenses $1.300M $1.106M $1.040M
YoY Change 10.17% 6.38% 2.96%
Operating Profit -$1.095M -$1.051M -$989.0K
YoY Change -16.8% 6.27% 20.01%
Interest Expense $70.00K $100.00
YoY Change -119.44%
% of Operating Profit
Other Income/Expense, Net $0.00 $97.46K -$1.094M
YoY Change -108.9% -1103.31%
Pretax Income -$1.030M -$950.0K -$2.080M
YoY Change -38.69% -54.33% 188.89%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.035M -$953.6K -$2.083M
YoY Change -38.33% -54.23% 191.37%
Net Earnings / Revenue -77.17% -82.34% -183.67%
Basic Earnings Per Share
Diluted Earnings Per Share -$18.76K -$17.31K -$48.93K
COMMON SHARES
Basic Shares Outstanding 54.91M shares 54.88M shares 41.54M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.59M $10.16M $23.70M
YoY Change -17.48% -57.13% 544.02%
Cash & Equivalents $5.227M $1.078M $23.70M
Short-Term Investments $9.360M $9.080M
Other Short-Term Assets $26.69K $220.0K $210.0K
YoY Change 0.0% 4.76% 0.0%
Inventory $404.0K $460.0K $387.0K
Prepaid Expenses
Receivables $1.049M $1.040M $805.3K
Other Receivables $19.62K $10.00K $0.00
Total Short-Term Assets $16.33M $11.89M $25.11M
YoY Change -15.04% -52.64% 393.03%
LONG-TERM ASSETS
Property, Plant & Equipment $574.8K $660.0K $1.183M
YoY Change -43.53% -44.21% -36.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.110M $10.15M
YoY Change -5.37%
Other Assets $245.0K $650.0K $258.6K
YoY Change -7.21% 151.33% -11.91%
Total Long-Term Assets $6.678M $11.69M $2.093M
YoY Change -8.95% 458.63% -25.2%
TOTAL ASSETS
Total Short-Term Assets $16.33M $11.89M $25.11M
Total Long-Term Assets $6.678M $11.69M $2.093M
Total Assets $23.00M $23.58M $27.20M
YoY Change -13.36% -13.31% 244.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $500.0K $440.0K $610.0K
YoY Change -12.28% -27.87% 64.86%
Accrued Expenses $590.0K $440.0K $410.0K
YoY Change 1.72% 7.32% 46.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.092M $880.0K $1.021M
YoY Change -5.35% -13.79% 57.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.130M $1.110M $1.530M
YoY Change -21.53% -27.45% 68.13%
Total Long-Term Liabilities $1.130M $1.110M $1.530M
YoY Change -21.53% -27.45% 68.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.092M $880.0K $1.021M
Total Long-Term Liabilities $1.130M $1.110M $1.530M
Total Liabilities $2.221M $1.988M $2.546M
YoY Change -14.36% -21.93% 63.74%
SHAREHOLDERS EQUITY
Retained Earnings -$61.73M -$60.70M -$56.37M
YoY Change 6.34% 7.67% 10.32%
Common Stock $82.52M $54.88K $54.18K
YoY Change 150757.52% 1.3% 56.54%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.390K $8.390K $8.390K
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 13.20K shares 13.20K shares 13.20K shares
Shareholders Equity $20.78M $21.60M $24.65M
YoY Change
Total Liabilities & Shareholders Equity $23.00M $23.58M $27.20M
YoY Change -13.36% -13.29% 244.74%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$1.035M -$953.6K -$2.083M
YoY Change -38.33% -54.23% 191.37%
Depreciation, Depletion And Amortization $150.0K $140.0K $170.0K
YoY Change -16.67% -17.65% -5.56%
Cash From Operating Activities -$630.0K -$1.130M -$500.0K
YoY Change -36.36% 126.0% -34.21%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K -$40.00K $0.00
YoY Change 200.0%
Acquisitions
YoY Change
Other Investing Activities $4.750M $920.0K $0.00
YoY Change -130.84%
Cash From Investing Activities $4.700M $870.0K $0.00
YoY Change -130.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 70.00K 0.000 19.79M
YoY Change -82.05% -100.0%
NET CHANGE
Cash From Operating Activities -630.0K -1.130M -500.0K
Cash From Investing Activities 4.700M 870.0K 0.000
Cash From Financing Activities 70.00K 0.000 19.79M
Net Change In Cash 4.140M -260.0K 19.29M
YoY Change -125.84% -101.35% -2638.16%
FREE CASH FLOW
Cash From Operating Activities -$630.0K -$1.130M -$500.0K
Capital Expenditures -$60.00K -$40.00K $0.00
Free Cash Flow -$570.0K -$1.090M -$500.0K
YoY Change -41.24% 118.0% -34.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
586063 USD
isr Supplemental Common Stock Warrant Liability Reclassification
SupplementalCommonStockWarrantLiabilityReclassification
-17395 USD
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671 shares
CY2015Q1 us-gaap Liabilities
Liabilities
1987750 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
54884 USD
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2015Q1 us-gaap Treasury Stock Value
TreasuryStockValue
8390 USD
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82246857 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60696825 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23584335 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
59 USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54883845 shares
CY2015Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
240247 USD
CY2015Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
196976 USD
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27332 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
276138 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2057620 shares
us-gaap Adjustment For Amortization
AdjustmentForAmortization
34923 USD
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
60278 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.98
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
788107 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1988995 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.00
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
756657 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1821504 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.96
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
755364 USD
CY2015Q1 isr Percentage Of Royalty Rate Payable
PercentageOfRoyaltyRatePayable
0.01 pure
CY2015Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
396174 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.22
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
458636 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1032402 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1703825 USD
us-gaap Operating Expenses
OperatingExpenses
3194863 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3232432 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
214009 USD
us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
375605 USD
us-gaap Net Income Loss
NetIncomeLoss
-2646369 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2512859 shares
us-gaap Interest Expense
InterestExpense
3551 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-146746 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-5633 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2892464 USD
us-gaap Share Based Compensation
ShareBasedCompensation
64360 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
116817 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6602547 USD
isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
8607 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
145274 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style=" font: 10pt times new roman, times, serif; margin-top: 0; margin-bottom: 0;"> <tr style=" vertical-align: top; text-align: justify;"> <td style=" width: 0in; border-left: none; border-right: none; border-top: none; border-bottom: none;">&#160;</td> <td width="24px" style=" text-align: left; border: none; font-family: 'Times New Roman';"><strong>2.</strong></td> <td style=" text-align: justify; padding-left: 0.25in; font-family: 'times new roman'; border-left: none; border-right: none; border-top: none; border-bottom: none;"><strong>New Accounting Pronouncements</strong></td> </tr> </table> </div> <p style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div style=" display: inline; font-size: 13px; font-family: 'Times New Roman', Times, serif; font-variant: normal; font-weight: normal; font-style: normal; text-decoration: none; color: rgb(0, 0, 0);"> <p style=" color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0px; text-align: justify; background-color: white;"><font style=" background-color: white;">In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, "Revenue from Contracts with Customers" (ASU 2014-09), which supersedes the revenue recognition requirements in FASB Accounting Standards Codification (ASC) Topic 605, "Revenue Recognition". The guidance requires that an entity recognize revenue in a way that depicts the transfer of promised goods or services to customers in the amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods and services. The guidance will be effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period and is to be applied retrospectively, with early application not permitted. The Company is currently evaluating the new standard and its impact on the Company's consolidated financial statements. </font></p> <p style=" color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; background-color: white;">&#160;</p> <p style=" color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0px; text-align: justify; background-color: white;"><font style=" background-color: white;">In August 2014, the FASB issued ASU No. 2014-15&#151;Presentation of Financial Statements&#151;Going Concern. The guidance requires an entity's management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). If conditions or events exist that raise substantial doubt about an entity's ability to continue as a going concern, the guidance requires disclosure in the financial statements. The guidance will be effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. The Company is currently evaluating the new standard and its impact on the Company's consolidated financial statements.</font></p> </div> </div> </div>
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
439223 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
40 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-135198 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
38031 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-23469 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
77963 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14016 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
10031758 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
9110673 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3915514 USD
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
4744580 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
205431 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2649027 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54878297 shares
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3265795 USD
us-gaap Gross Profit
GrossProfit
-37569 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3303364 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
70789 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5961001 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
104818 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-43154 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9171 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y11M8D
isr Issuance Of Common Stock In Connection With Warrant Exercises Net Of Issuance Costs Shares
IssuanceOfCommonStockInConnectionWithWarrantExercisesNetOfIssuanceCostsShares
48573 shares
isr Class Of Warrant Or Right Issued In Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightIssuedInPeriodExercisePriceOfWarrantsOrRights
1.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
64360 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
IsoRay, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0000728387
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
9000 USD
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
65217 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
65000 shares
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
12720 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
1478703 USD
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
9000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13818927 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
133564 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
145275 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y6M29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y2M8D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
26333 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
15130 USD
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
9000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2213 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-4516 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-18551 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-99675 USD
us-gaap Share Based Compensation
ShareBasedCompensation
65217 USD
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
55109 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1014000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
23056 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3329950 USD
us-gaap Gross Profit
GrossProfit
-60308 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3269642 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38852980 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5015669 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
23063717 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15129 USD
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21546 USD
us-gaap Net Income Loss
NetIncomeLoss
-4281317 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1478703 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1800589 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5168 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16333 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2239197 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
10393 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-39759 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
30301 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
49752 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
177195 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
45 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
517548 USD
isr Supplemental Common Stock Warrant Liability Reclassification
SupplementalCommonStockWarrantLiabilityReclassification
440000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20802974 USD
isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
-18779 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3029948 shares
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7974 USD
us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
726378 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1013436 USD
us-gaap Interest Expense
InterestExpense
827 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1391 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3267881 USD
us-gaap Operating Expenses
OperatingExpenses
3207573 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1805732 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
931210 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
470631 USD
CY2013Q3 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
726378 USD
CY2013Q3 isr Gross Proceeds From Issuance Of Stock
GrossProceedsFromIssuanceOfStock
3700000 USD
CY2013Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3279292 USD
CY2014Q1 isr Liability For Common Stock Issuable
LiabilityForCommonStockIssuable
35470 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23702901 USD
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41540982 shares
CY2014Q1 isr Gross Proceeds From Issuance Of Stock
GrossProceedsFromIssuanceOfStock
14675180 USD
CY2014Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13818927 USD
CY2014Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
444747 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.43
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329 shares
CY2014Q2 us-gaap Inventory Net
InventoryNet
359737 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
34999 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7680073 USD
CY2014Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
151321 USD
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
173417 USD
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54701708 shares
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
28605 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
100 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
574855 USD
CY2014Q2 us-gaap Assets
Assets
26549255 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
264076 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
59 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26549255 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
23955768 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58050456 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81959853 USD
CY2014Q2 us-gaap Treasury Stock Value
TreasuryStockValue
8390 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
54702 USD
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54701708 shares
CY2014Q2 us-gaap Liabilities
Liabilities
2593487 USD
CY2014Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
866560 USD
CY2014Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
573000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1153927 USD
CY2014Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
120765 USD
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
236282 USD
CY2014Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
141592 USD
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
80433 USD
CY2014Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
469758 USD
CY2014Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181208 USD
CY2014Q2 us-gaap Long Term Investments
LongTermInvestments
5401398 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1017915 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
19214900 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
206047 USD
CY2014Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
53082 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
913049 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
38607 USD
CY2014Q2 us-gaap Short Term Investments
ShortTermInvestments
10002912 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2899927 USD
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3231 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0185 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.58
CY2013Q3 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
25150 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.58
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.59
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3231 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0177 pure
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.59
CY2013Q3 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
6906 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21453 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1158109 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1102912 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
55197 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
141399 USD
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
374876 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
589934 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
1106209 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1051012 USD
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
68954 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
97459 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-953553 USD
CY2015Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
USD
CY2015Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-2658 USD
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-950895 USD
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
556 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-988995 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1039901 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
640732 USD
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
245558 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
153611 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
50906 USD
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1083413 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1134319 USD
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54883551 shares
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
42506077 shares
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2086097 USD
CY2014Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658 USD
CY2014Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-2083439 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1094444 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
USD
CY2014Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1095000 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13433 USD
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38419502 shares
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54907185 shares

Files In Submission

Name View Source Status
0001144204-15-031550-index-headers.html Edgar Link pending
0001144204-15-031550-index.html Edgar Link pending
0001144204-15-031550.txt Edgar Link pending
0001144204-15-031550-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
isr-20150331.xml Edgar Link completed
isr-20150331.xsd Edgar Link pending
isr-20150331_cal.xml Edgar Link unprocessable
isr-20150331_def.xml Edgar Link unprocessable
isr-20150331_lab.xml Edgar Link unprocessable
isr-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v409624_10q.htm Edgar Link pending
v409624_ex10-82.htm Edgar Link pending
v409624_ex31-1.htm Edgar Link pending
v409624_ex31-2.htm Edgar Link pending
v409624_ex32.htm Edgar Link pending